{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:51:25Z","timestamp":1791438685581,"version":"4.3.3"},"reference-count":27,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Acta Clinica Belgica"],"DOI":"10.1080\/17843286.2026.2736302","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:07:53Z","timestamp":1791436073000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["CAR T-cell therapy for relapsed and refractory B-cell non-Hodgkin lymphoma: a single-centre 5-year real-world experience study at Ghent University Hospital"],"prefix":"10.1080","author":[{"given":"Julie","family":"Vandewiele","sequence":"first","affiliation":[{"name":"UZ Gent","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiel","family":"Gharakhani","sequence":"additional","affiliation":[{"name":"UZ Gent","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciel","family":"De Vriendt","sequence":"additional","affiliation":[{"name":"Ghent University Hospital","place":["Ghent, Belgium"]},{"name":"Ghent University","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Daneels","sequence":"additional","affiliation":[{"name":"Ghent University Hospital","place":["Ghent, Belgium"]},{"name":"Ghent University","place":["Ghent, Belgium"]},{"name":"Ghent University","place":["Ghent, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.824704"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071929"},{"key":"e_1_3_6_4_1","unstructured":"Holmberg L Sandmaier B. Determining eligibility for autologous hematopoietic cell transplantation. UpToDate; 2024. https:\/\/www.uptodate.com\/contents\/determining-eligibility-for-autologous-hematopoietic-cell-transplantation"},{"key":"e_1_3_6_5_1","doi-asserted-by":"crossref","unstructured":"Maddocks K. Update on mantle cell lymphoma [internet]. Vol. 132 Blood. 2018. Available from: http:\/\/ashpublications.org\/blood\/article-pdf\/132\/16\/1647\/1406983\/blood791392.pdf","DOI":"10.1182\/blood-2018-03-791392"},{"issue":"5","key":"e_1_3_6_6_1","first-page":"702","article-title":"Incidence and survival trends in mantle cell lymphoma","volume":"181","author":"Eppperla N","year":"2017","unstructured":"Eppperla N, Hamadani M, Fenske T, et al. Incidence and survival trends in mantle cell lymphoma. Br J Haematol. 2017;181(5):702\u2013706.","journal-title":"Br J Haematol"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306220"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0976"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3703"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0023-2"},{"key":"e_1_3_6_11_1","doi-asserted-by":"crossref","unstructured":"Martin P Maddocks K Leonard JP et al. Postibrutinib outcomes in patients with mantle cell lymphoma. 2016; Available from: http:\/\/ashpublications.org\/blood\/article-pdf\/127\/12\/1559\/1392437\/1559.pdf","DOI":"10.1182\/blood-2015-10-673145"},{"issue":"10","key":"e_1_3_6_12_1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ajh.26301","article-title":"Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed\/refractory aggressive B-cell lymphomas: observations from the JULIET, ZUMA-1, and transcend trials","volume":"96","author":"Westin JR","year":"2021","unstructured":"Westin JR, Kersten MJ, Salles G, et al. Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed\/refractory aggressive B-cell lymphomas: observations from the JULIET, ZUMA-1, and transcend trials. American Journal of Hematology. 2021;96(10):1295\u20131312.","journal-title":"American Journal of Hematology"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1630"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001305"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425787"},{"issue":"1","key":"e_1_3_6_18_1","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1182\/blood-2024-206736","article-title":"The Prognostic value of MTV is Retained in New proposed SUV 4 threshold: an international comparison of follicular and Hodgkin patient survival","volume":"144","author":"Chauvie S","year":"2024","unstructured":"Chauvie S, Guerra L, Fallanca F, et al. The Prognostic value of MTV is Retained in New proposed SUV 4 threshold: an international comparison of follicular and Hodgkin patient survival. Blood [Internet]. 2024;144(Supplement 1):6254. Available from: https:\/\/ashpublications.org\/blood\/article\/144\/Supplement%201\/6254\/528958\/The-Prognostic-Value-of-MTV-Is-Retained-in-New","journal-title":"Blood"},{"issue":"9","key":"e_1_3_6_19_1","first-page":"e581.1","article-title":"Real-world evidence of Axicabtagene Ciloleucel for the treatment of large B cell lymphoma in the United States","volume":"28","author":"Jacobson Ca C","year":"2022","unstructured":"Jacobson Ca C, Locke FL, Ma L, et al. Real-world evidence of Axicabtagene Ciloleucel for the treatment of large B cell lymphoma in the United States. Transpl Cell Ther. 2022;28(9):.e581.1\u2013.e581.8.","journal-title":"Transpl Cell Ther"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2024.2399365"},{"issue":"4","key":"e_1_3_6_21_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee DW","year":"2019","unstructured":"Lee DW, Santomasso BD, Locke FL, et al. ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biology of Blood and Marrow Transplantation. 2019;25(4):625\u2013638.","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116133"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01969-y"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2020.09.001"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006923"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"}],"container-title":["Acta Clinica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17843286.2026.2736302","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17843286.2026.2736302","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17843286.2026.2736302","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:07:55Z","timestamp":1791436075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17843286.2026.2736302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":27,"alternative-id":["10.1080\/17843286.2026.2736302"],"URL":"https:\/\/doi.org\/10.1080\/17843286.2026.2736302","relation":{},"ISSN":["1784-3286","2295-3337"],"issn-type":[{"value":"1784-3286","type":"print"},{"value":"2295-3337","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yacb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yacb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}